Oral Microbiome Alterations and SARS-CoV-2 Saliva Viral Load in Patients with COVID-19Original paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study asked whether the saliva microbiome relates to SARS-CoV-2 infection and to how much virus is present in saliva. Researchers compared newly hospitalized COVID-19 patients with SARS-CoV-2 negative controls. They used 16S rRNA gene sequencing to profile saliva bacteria. They also ran reverse transcription PCR on saliva to measure viral load using cycle threshold values. Diversity, community composition, and individual taxa were compared by COVID-19 status and by saliva viral load. Statistics included Kruskal-Wallis tests, PERMANOVA, and DESeq2 differential abundance.
Who was studied?
The cohort was 53 hospitalized COVID-19 patients and 59 SARS-CoV-2 negative hospitalized controls at Columbia University Irving Medical Center in New York City. Saliva was self-collected within 24 hours of admission during the 2020 outbreak peak. Adults 18 years or older were eligible if not intubated or in intensive care. Mean age was about 56 years in both groups. The cohort included many Black and Hispanic patients. Microbiome sequencing succeeded for 46 patients and 54 controls.
What were the most important findings?
The saliva microbiome did not differ meaningfully between COVID-19 patients and controls. Shannon diversity comparison gave p equals 0.10, and community-level PERMANOVA gave p equals 0.11, with only three sequence variants differing. Within COVID-19 patients, however, saliva viral load was linked to many differentially abundant taxa. These shifts largely persisted after adjusting for supplemental oxygen. Saliva RT-PCR had 65.1% sensitivity and 98.1% specificity versus nasopharyngeal swabs. Detectable saliva virus was found in 28 of 53 patients, about 62%.
What are the greatest implications of this study?
The findings suggest SARS-CoV-2 presence alone may not markedly reshape the oral microbiome, but viral load in saliva coincides with specific bacterial shifts. This points to possible bacterial-viral interactions that could matter for disease course. The authors frame these as associations needing larger studies, not proven causes. Clinical outcomes were rare, so links to severity could not be established. Saliva testing showed lower sensitivity than some prior reports, which may reflect less severe patients and difficulty producing quality saliva samples.